(Q37972015)

26 August 2017

title

Drug treatment of hyperuricemia to prevent cardiovascular outcomes: are we there yet? (English)

1 reference

ORCID Public Data File 2021

26 August 2017

1 reference

1 reference

author name string

Angelo L Gaffo

series ordinal

1

1 reference

26 August 2017

Kenneth G Saag

series ordinal

2

1 reference

26 August 2017

publication date

1 February 2012

1 reference

American journal of cardiovascular drugs

26 August 2017

published in

1 reference

26 August 2017

volume

12

1 reference

26 August 2017

issue

1

1 reference

26 August 2017

page(s)

1-6

1 reference

The influence of temperature on the solubility of monosodium urate

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F11594580-000000000-00000

Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594580-000000000-00000

Asymptomatic hyperuricemia: impact of ultrasonography.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594580-000000000-00000

Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594580-000000000-00000

Gout is on the increase in New Zealand

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594580-000000000-00000

Mild hyperuricemia induces glomerular hypertension in normal rats

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594580-000000000-00000

Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594580-000000000-00000

Treatment with the xanthine oxidase inhibitor febuxostat lowers uric acid and alleviates systemic and glomerular hypertension in experimental hyperuricaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594580-000000000-00000

Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594580-000000000-00000

Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594580-000000000-00000

Predictors of an increased risk of future hypertension in Utah. A screening analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594580-000000000-00000

Hyperinsulinemia for the development of hypertension: data from the Hawaii-Los Angeles-Hiroshima Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594580-000000000-00000

Hyperuricemia and incidence of hypertension among men without metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594580-000000000-00000

Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594580-000000000-00000

Serum uric acid predicts incident hypertension in a biethnic cohort: the atherosclerosis risk in communities study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594580-000000000-00000

Hyperuricemia as a predictor of hypertension in a screened cohort in Okinawa, Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594580-000000000-00000

Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594580-000000000-00000

Uric acid and the development of hypertension: the normative aging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594580-000000000-00000

Precursors of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594580-000000000-00000

The association between serum uric acid level and long-term incidence of hypertension: Population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594580-000000000-00000

Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594580-000000000-00000

Serum uric acid and the risk for hypertension and Type 2 diabetes in Japanese men: The Osaka Health Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594580-000000000-00000

Hyperuricemia and incident hypertension: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594580-000000000-00000

Plasma uric acid and hypertension in a Chinese community: prospective study and metaanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594580-000000000-00000

Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594580-000000000-00000

Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594580-000000000-00000

Hyperuricemia and risk of stroke: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594580-000000000-00000

Hyperuricemia and incident heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594580-000000000-00000

Uric acid level and allopurinol use as risk markers of mortality and morbidity in systolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594580-000000000-00000

Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594580-000000000-00000

Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594580-000000000-00000

Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594580-000000000-00000

A causal role for uric acid in fructose-induced metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594580-000000000-00000

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594580-000000000-00000

Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594580-000000000-00000

EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594580-000000000-00000

Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594580-000000000-00000

Beer, liquor, and wine consumption and serum uric acid level: the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594580-000000000-00000

Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594580-000000000-00000

Serum urate and its relationship with alcoholic beverage intake in men and women: findings from the Coronary Artery Risk Development in Young Adults (CARDIA) cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594580-000000000-00000

Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594580-000000000-00000

Gout therapeutics: new drugs for an old disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594580-000000000-00000

Optimal treatment of knee monarthritis in juvenile idiopathic arthritis: a decision analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594580-000000000-00000

Serum Uric Acid and Risk for Cardiovascular Disease and Death: The Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594580-000000000-00000

10.2165/11594580-000000000-00000

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

26 August 2017

1048310285

0 references

1 reference